propafenone has been researched along with Obstructive Lung Diseases in 2 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, BL | 1 |
| Dohrmann, ML | 1 |
| Veale, D | 1 |
| McComb, JM | 1 |
| Gibson, GJ | 1 |
2 other studies available for propafenone and Obstructive Lung Diseases
| Article | Year |
|---|---|
Theophylline toxicity after propafenone treatment: evidence for drug interaction.
Topics: Aged; Drug Interactions; Humans; Lung Diseases, Obstructive; Male; Propafenone; Theophylline | 1992 |
Propafenone.
Topics: Adult; Asthma; Female; Forced Expiratory Volume; Humans; Lung Diseases, Obstructive; Propafenone | 1990 |